Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-40411813 in Schizophrenia
NCT01323205Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- May 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of adx-71149 in schizophrenia, sponsored by Janssen Pharmaceutical. Started May 2011; status: completed.
02
Drugs
adx-71149
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01323205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01323205.